PRQR - ProQR Therapeutics BV
ProQR Therapeutics BV Logo

PRQR - ProQR Therapeutics BV

https://www.proqr.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. The company is headquartered in Leiden, the Netherlands.

52W High
$4.62
52W Low
$1.07
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.35
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-2.10
EV/Revenue (<3 favorable)
7.19
P/S (TTM) (<3 favorable)
15.06
P/B (<3 favorable)
3.31
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
18.04%
Institutions (25–75% balanced)
51.67%
Shares Outstanding
105,344,000
Float
66,830,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
17,140,000
Gross Profit (TTM)
17,140,000
EPS (TTM)
-0.47
Profit Margin (>10% good)
-2.31%
Operating Margin (TTM) (higher better)
-3.08%
ROE (TTM) (>15% strong)
-0.80%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.39
Momentum
Bearish momentum
Value
0.0389
Previous
0.0526
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025